Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 4 more changesShow less
    • Final enrollment: 223 participants (planned 2)
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 8 words
    • Study description revised
  2. Start date: Feb 3, 2026 to Apr 23, 2026v3
  3. Start date: Dec 30, 2025 to Feb 3, 2026
    • Primary completion date: Apr 30, 2026 to May 30, 2026
    • Study completion date: May 30, 2026 to Jun 30, 2026
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zeliha Alicikus
4 trials monitored
See all monitored trials
Obesity
3,888 trials monitored
See 157 trials at risk
This study aims to compare the incidence and characteristics of peri-intubation adverse airway events in critically ill trauma patients with morbid obesity versus those with super obesity, and to determine whether increasing BMI independently predicts severe peri-intubation complications.
Trial Details
NCT Number NCT07297420
Lead Sponsor Zeliha Alicikus
Conditions
(from sponsor)		 Obesity, Airway Complication of Anesthesia, Intubation; Difficult or Failed
Related terms Obesity
Enrollment 223 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov